A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.


Updates from The Motley Fool

Latest updates on Agenus from Fool.com.


Stock Performance

AGEN vs. S&P 500 | 2 Year Performance
View Interactive AGEN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Agenus.
Current Price: $7.20
Prev Close: $7.03
Open: $7.07
Bid: $6.95
Ask: $7.23
Day's Range: $7.00 - $7.21
52wk Range: $2.61 - $7.30
Volume: 1,192,739
Avg Vol 1,200,191
Market Cap: $609.45M
P/E (ttm): -7.10
EPS (ttm): -$0.99
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Agenus.
CAPS Rating 3 out of 5
 
209 Outperform
83 Underperform
CAPS All Stars
 
37 Outperform
30 Underperform

How do you think Agenus will perform against the market?



You pick for Agenus is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Garo H. Armen, CEO

56% Approve

Based on 2 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Agenus.

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers